论文部分内容阅读
目的探究集束治疗在重症肺炎与感染性休克患者中的应用效果。方法择取2014年12月~2016年12月期间由笔者所在医院收治的80例重症肺炎和感染性休克患者,以随机数字法将其分入两组并采取不同治疗措施,分别为:采取集束治疗的40例研究组患者、采取脏器支持加抗感染等常规治疗的40例对照组患者。对比两组患者的治疗效果及相关指标。结果研究组在住院时间上短于对照组,其死亡率和多器官衰竭综合征(MODS)发生率分别为2.5%和12.5%,低于对照组15%和42.5%的MODS发生率与死亡率,差异有统计学意义(P<0.05)。结论在重症肺炎与感染性休克患者中采取集束治疗可以降低患者的死亡率,预防多器官衰竭,加快患者的康复速度。
Objective To explore the effect of cluster therapy in patients with severe pneumonia and septic shock. Methods Eighty patients with severe pneumonia and septic shock who were admitted to our hospital from December 2014 to December 2016 were randomly divided into two groups according to random number method and were treated with different treatments, Forty patients in the study group were enrolled in the control group of 40 patients who received conventional therapy including organ support and anti-infection. Comparison of two groups of patients with treatment and related indicators. Results The study group was shorter than the control group in hospitalization time, and its mortality rate and multiple organ failure syndrome (MODS) rates were 2.5% and 12.5%, respectively, lower than the control group 15% and 42.5% MODS incidence and mortality , The difference was statistically significant (P <0.05). Conclusion Cluster therapy in patients with severe pneumonia and septic shock can reduce the mortality of patients, prevent multiple organ failure and speed up the recovery of patients.